Aller au contenu
Capteurs et mesuresRevue des preuves3 min read

Wrist trackers: good for steps and heart rate, poor for calories burned

Collectif éditorial MoveVitals · Study published · Reading updated

Original paper:Accuracy and Acceptability of Wrist-Wearable Activity-Tracking Devices: Systematic Review of the Literature. · Journal of medical Internet research · 2022 · Article original ↗

À retenir

A review of 65 articles found Fitbit Charge models had a mean absolute percentage error (MAPE) under 25% for steps across 20 studies, and the Apple Watch under 10% for heart rate in 2 studies, while energy expenditure error exceeded 30% for every brand. Studies differed too much to pool, so these are descriptive patterns rather than a ranking of devices.

Study design

Revue des preuves

Reading basis

Published abstract

Reading focus

Design & applicability

Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.

Question de recherche

Many wrist-worn trackers exist, but it is hard to know how accurate they are and whether people will keep wearing them. The authors reviewed the literature on the accuracy and acceptability, meaning willingness to use the device, of wrist trackers that measure physical activity in the general population.

Population et méthode

Systematic review. MEDLINE, Embase, the Cochrane Central Register of Controlled Trials and SPORTDiscus were searched for studies measuring physical activity in the general population with wrist-wearable trackers. Articles were screened, and data on setting, population, outcome measured and risk of bias were reported. No meta-analysis was done because of substantial clinical heterogeneity. Accuracy was summarized as mean absolute percentage error (MAPE).

Résultats

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    65 articles were included, assessing accuracy for 14 outcomes grouped as counts of specific activities (including steps), time spent active, intensity (including energy expenditure), heart rate, distance and speed. Step counts, heart rate and energy expenditure were assessed most often.
  2. 2
    Steps: the Fitbit Charge (or Charge HR) had a MAPE below 25% across 20 studies. Heart rate: the Apple Watch had a MAPE below 10% in 2 studies.
  3. 3
    Energy expenditure: MAPE was above 30% for all brands, showing poor accuracy across devices.
  4. 4
    Acceptability was most often measured through data availability and wearing time. Data availability was 75% or higher for the Fitbit Charge HR, Fitbit Flex 2 and Garmin Vivofit, and wearing time was 89% for both the GENEActiv and Nike FuelBand.

Limites et incertitude

  1. 1
    Substantial clinical heterogeneity prevented a meta-analysis, so the accuracy figures are summaries of separate studies with different protocols, populations and reference measures.
  2. 2
    Evidence is thin for some headline claims: the Apple Watch heart rate finding rests on 2 studies, and many tested devices (such as Fitbit Charge and Vivofit) are older models than those on sale now.
  3. 3
    Acceptability was measured indirectly through data availability and wearing time, not by asking users, and the abstract does not report the risk-of-bias results. This reading is based on the abstract only.

Mise en perspective

Wrist trackers looked fairly reliable for counting steps and, for the Apple Watch, for heart rate, so those numbers are reasonable to follow. Calorie estimates were poor for every brand tested, so treat them as rough guesses and do not use them to set strict food targets. Findings from older device models may not carry over to newer ones.

Vos données

Rely on your device's steps and heart rate for week-to-week trends and treat the energy expenditure figure as ballpark only. Stick with the same device and wear it on the same wrist, since comparing numbers across brands or against other people's is where the largest errors appear.

Comprendre ce type de preuve

Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.

Résumé structuré des auteurs English

Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.

Background

Numerous wrist-wearable devices to measure physical activity are currently available, but there is a need to unify the evidence on how they compare in terms of acceptability and accuracy.

Objective

The aim of this study is to perform a systematic review of the literature to assess the accuracy and acceptability (willingness to use the device for the task it is designed to support) of wrist-wearable activity trackers.

Methods

We searched MEDLINE, Embase, the Cochrane Central Register of Controlled Trials, and SPORTDiscus for studies measuring physical activity in the general population using wrist-wearable activity trackers. We screened articles for inclusion and, for the included studies, reported data on the studies' setting and population, outcome measured, and risk of bias.

Results

A total of 65 articles were included in our review. Accuracy was assessed for 14 different outcomes, which can be classified in the following categories: count of specific activities (including step counts), time spent being active, intensity of physical activity (including energy expenditure), heart rate, distance, and speed. Substantial clinical heterogeneity did not allow us to perform a meta-analysis of the results. The outcomes assessed most frequently were step counts, heart rate, and energy expenditure. For step counts, the Fitbit Charge (or the Fitbit Charge HR) had a mean absolute percentage error (MAPE) <25% across 20 studies. For heart rate, the Apple Watch had a MAPE <10% in 2 studies. For energy expenditure, the MAPE was >30% for all the brands, showing poor accuracy across devices. Acceptability was most frequently measured through data availability and wearing time. Data availability was ≥75% for the Fitbit Charge HR, Fitbit Flex 2, and Garmin Vivofit. The wearing time was 89% for both the GENEActiv and Nike FuelBand.

Conclusions

The Fitbit Charge and Fitbit Charge HR were consistently shown to have a good accuracy for step counts and the Apple Watch for measuring heart rate. None of the tested devices proved to be accurate in measuring energy expenditure. Efforts should be made to reduce the heterogeneity among studies.

Sources et attribution

Accuracy and Acceptability of Wrist-Wearable Activity-Tracking Devices: Systematic Review of the Literature.

Germini F, Noronha N, Borg Debono V, Abraham Philip B, Pete D, Navarro T, Keepanasseril A, Parpia S, de Wit K, Iorio A.

Journal of medical Internet research · 2022-01-21

DOI: 10.2196/30791 ↗PubMed · 35060915 ↗Europe PMC · Licence indiquée: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée

Sources vérifiées 2026-11-01

Guides pratiques

À lire ensemble

·Étude de cohorte

Activity–stroke and heart attack curves differ by accelerometer processing method

Among 90,237 UK Biobank adults free of cardiovascular disease at baseline, followed until December 2022 for 1,298 strokes and 2,031 myocardial infarctions, the shape of the link between moderate-vigorous physical activity (MVPA) and each outcome depended on how the accelerometer data were processed. For stroke, hazard fell in a straight line only with the machine-learning metric; for myocardial infarction, two metrics gave a curved decline and activity counts a straight one. The abstract gives no hazard ratios, so it shows that methods disagree, not which one is right, and the findings are observational associations.

Preventive Medicine

Explications approfondiesLire l’étude →
·Validation : étude/revue

Smartwatch data as forensic evidence: heart rate is best validated, the rest uneven

A systematic review and meta-analysis of studies on smartwatches from four major brands, framed around digital forensics, found that heart rate was both the most studied and the most accurate measure. Step count, distance, energy expenditure, activity classification and sleep were less consistently validated, and results varied by brand, protocol and reporting. The abstract gives no pooled numbers, and most studies were run in healthy people in laboratories, so it cannot say how a particular watch performs for a particular person in daily life.

Forensic Science International

Explications approfondiesLire l’étude →
·Synthèse de revues

Activity trackers: about 1,800 more steps a day, but small effects on other outcomes

An umbrella review of 39 systematic reviews and meta-analyses, covering 163,992 participants, found that activity trackers were associated with more physical activity (SMD 0.3–0.6), equating to about 1,800 extra steps and 40 minutes more walking per day, and with a bodyweight reduction of about 1 kg. Effects on blood pressure, cholesterol, glycosylated haemoglobin, quality of life and pain were typically small and often non-significant. The abstract does not say what else came with the trackers in these programs or how much the reviews overlap, so the gains cannot be credited to the device alone.

The Lancet Digital Health

Explications approfondiesLire l’étude →
·Validation : étude/revue

Seven sleep trackers: good at spotting sleep, weak on wake and sleep stages

In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.

Sleep

Explications approfondiesLire l’étude →
Capteurs et mesures →